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Abstract
The vaccinia virus temperature-sensitive mutations Cts6 and Cts9 were mapped by marker rescue and DNA sequencing to the A28 gene. Cts6
and Cts9 contain an identical 2-bp deletion truncating the A28 protein and removing the fourth conserved cysteine near the C-terminus. Cts9
mutant virions produced at 40 °C were non-infectious and unable to cause cytopathic effect. However, the mutant A28 protein localized to purified
mature virions (MV) at 31 °C and 40 °C. MVof Cts9 produced at 40 °C bound to cells but did not enter cells. Low pH treatment of Cts9-infected
cells at 18 h p.i. failed to produce fusion from within at 40 °C, but gave fusion at 31 °C. Adsorption of Cts9 mutant virions to cells followed by
low pH treatment showed a defect in fusion from without. The Cts9 phenotype suggests that the A28 protein is involved in both virus entry and
cell–cell fusion, and supports the linkage between the two processes.
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The poxviruses are a large and diverse group of DNAviruses
that replicate in the cytoplasm of infected cells (Moss, 2001).
Many aspects of their life cycle, including DNA replication,
transcription, and immune evasion, are relatively well under-
stood, and significant progress has been made in unraveling the
complex process of virion morphogenesis (reviewed in Condit
et al., 2006 and Smith et al., 2002). However, until recently little
was known about the process by which poxvirus particles gain
access to the cytoplasm of susceptible cells.
Vaccinia virus (VV) is the best-studied poxvirus, and
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doi:10.1016/j.virol.2007.03.060form, MV (mature virion), which is surrounded by a single lipid
bilayer membrane, and an extracellular form, EV (extracellular
virion), which is surrounded by two lipid bilayer membranes.
During morphogenesis MV is wrapped with a Golgi-derived
double membrane to produce a wrapped form, WV (wrapped
virion), covered with three membrane layers. During fusion of
WV with the cell membrane, the outermost envelope is lost,
generating EV that is either released from infected cells or
remains attached at the cell surface.
Binding of MV to the cell surface is thought to be mediated
at least partly by three virion proteins that bind to glycosami-
noglycans, namely D8, which binds chondroitin sulfate (Hsiao
et al., 1999), and the heparan sulfate-binding proteins A27
(Chung et al., 1998) and H3 (Lin et al., 2000). However, none of
these proteins is essential for virus attachment, and studies with
soluble glycosaminoglycans and polyanions have shown either
relatively modest reductions in infection, or no effect,
depending on the cell line (Carter et al., 2005).
Entry of MV into cells is thought to occur by fusion between
the membrane of MV and the cell membrane, either directly at
the cell surface (Carter et al., 2005) or following internalization
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may occur on infection of the same host cells, and the net effect
is the release of virus cores into the cytoplasm, followed by
uncoating and early transcription. Based on electron micro-
scopy, the EV form sheds its outer membrane by a non-
fusogenic mechanism at the cell surface, and the released MV
underneath the broken EV membrane or “shroud” then fuses
with the plasma membrane (Law et al., 2006). Thus, although
the EV and MV particles may interact with different cellular
attachment factors (Vanderplasschen et al., 1998), the entry
pathways converge at the step of MV fusion with the cell
membrane. Cell–cell fusion mediated by EV at the surface of
infected cells (fusion from within) or by MVadded exogenously
to cells (fusion from without) is triggered by low pH treatment
(Gong et al., 1990), and probably reflects the natural process of
virus fusion to cell membranes within endosomes.
Temperature-sensitive mutants of VV have been useful in
defining roles for essential genes in virus morphogenesis, as
have inducible mutants in which a specific gene is only
expressed in the presence of an inducer. Several conserved MV
surface membrane proteins have recently been shown to be
required for the entry of virus particles into the cytoplasm,
including A28 (Senkevich et al., 2004b), H2 (Senkevich and
Moss, 2005), A21 (Townsley et al., 2005b), L5 (Townsley et al.,
2005a), A16 (Ojeda et al., 2006b), G3 (Izmailyan et al., 2006),
and G9 (Ojeda et al., 2006a). Inducible mutants for any one of
these seven genes have the same phenotype, and are defective in
virus entry and in causing fusion from within and fusion from
without. In the absence of any one of these proteins, normal
virion assembly occurs, and binding of MV to cells is
unaffected. The seven proteins together with J5 have been
reported to associate in an “entry–fusion” complex (Senkevich
et al., 2005). In addition the VV F9 protein is required for virus
entry, and interacts with proteins of the complex (Brown et al.,
2006).
Orthologs of the vaccinia A28 protein are found in
poxviruses belonging to both the Entomopoxvirinae and
Chordopoxvirinae subfamilies, and in all cases there is complete
conservation of the four cysteine residues which are known in
the VV WR A28 protein to participate in two intramolecular
disulfide bonds formed by the vaccinia-encoded redox pathway
(Senkevich et al., 2002, 2004a). Our studies with a temperature-
sensitive VV mutant in the A28 protein show that deletion of 14
amino acids from the A28 C-terminus, including the fourth
conserved cysteine residue, surprisingly results in a virus that is
viable at 31 °C. However, at 40 °C the A28 ts mutant
synthesizes mature virions that are unable to enter cells, and are
defective in mediating cell–cell fusion following low pH
treatment.
Results
Mapping of the mutations Cts6 and Cts9 to the A28 gene
region by marker rescue
The temperature-sensitive vaccinia virus mutants Cts6 and
Cts9 comprise a complementation group that has a “normal”phenotype, that is, they display wild-type protein and DNA
synthesis at the nonpermissive temperature of 40 °C (Condit
and Motyczka, 1981). Recombination between the two mutants
was undetectable, suggesting that the mutations lie close
together (Condit and Motyczka, 1981). Using a library of
overlapping cosmid clones, Thompson and Condit (1986)
showed that Cts6 mapped to an approximately 3-kb region of
DNA located in the middle of the HindIII A fragment of the
vaccinia genome. Further preliminary mapping (not shown)
using 5-kb PCR products spanning this region (Luttge and
Moyer, 2005) showed that the mutation was apparently within a
DNA fragment LM32 comprising genes A25.3L (part of the
fragmented ATI gene) through A29L (Fig. 1).
Initial attempts at fine mapping the mutations using PCR
products corresponding precisely to individual open reading
frames within this region did not result in a significant rescue
(data not shown). We therefore attempted marker rescue using
PCR products that incorporated two or more adjacent genes,
specifically A25L-A26L, A25L-A27L, A27L-A28L, A27L-
A29L, and A28L-A29L. Fig. 1 shows a subset of the results
demonstrating that rescue of Cts6 did not occur with products
containing A25L-A27L, A28L-A29L, or with A27L or A28L
alone, however rescue was observed with PCR DNA containing
both A27L and A28L. Similar results were obtained with Cts9
(not shown). This result suggests that the mutations map near
the 5′ end of A27L or at the 3′ end of A28L.
Cts6 and Cts9 contain an identical mutation resulting in
truncation of the A28 protein prior to the fourth conserved
cysteine residue
To determine precisely the mutations that cause the
temperature sensitivity in Cts6 and Cts9, the A27L and A28L
genes from both viruses were sequenced. The A27L gene from
both viruses was wild type in DNA sequence, however both
mutants contained a two nucleotide deletion near the 3′ end of
the A28L gene (Fig. 2A), consistent with the marker rescue
results. The observation that the mutations in the two viruses are
identical is in agreement with the fact that recombination
between the two mutants was undetectable (Condit and
Motyczka, 1981). The mutants were isolated at different times
using a hydroxylamine mutagenesis protocol, which should
cause nucleotide substitutions rather than deletions (Condit and
Motyczka, 1981). We speculate that the mutants were in fact
pre-existing siblings present in the stock of virus used in the
mutagenesis.
The deletion of two adjacent G residues causes a translation
frameshift at codon 132 followed by a premature termination
after two further codons, generating a C-terminal truncated
protein 134 amino acids in length (Figs. 2B, C). The wild-type
A28 protein is 146 amino acids in length and contains five
cysteine residues. The first cysteine, at position 17, lies within
the predicted N-terminal transmembrane domain (Fig. 2C) and
is not conserved in all poxvirus orthologs. The remaining four
cysteine residues are completely conserved in all known A28
orthologs (Senkevich et al., 2004a), including those from the
insect poxviruses Amsacta moorei entomopoxvirus and
Fig. 1. Marker rescue of Cts6. At the top is a diagram of a 7-kb region of the vaccinia genome within which Cts6 has been previously mapped, including genes A25L
through A29L. Genes are represented by arrows, with the gene name and protein function indicated above. The horizontal lines immediately below represent a subset
of PCR products used in the rescue of Cts6. The gene(s) included in each PCR product are indicated to the right of the product; LM32 corresponds to a 5-kb PCR
product used in preliminary studies. The bottom of the figure shows selected crystal violet stained 60-mm dishes resulting from the marker rescue, with the
corresponding PCR product labeled below the dish. Note that within the region comprising the non-essential genes A25L and A26L, the Copenhagen DNA sequence,
from which the familiar gene nomenclature is derived, differs significantly from the WR sequence. In WR, the A type inclusion (ATI) gene is fragmented into 4 ORFs
which we have called A25L, A25.1L, A25.2L and A25.3L. These 4 ORFs correspond to VACWR145, VACWR146, VACWR147 and VACWR148 respectively in the
Poxvirus Bioinformatics Resource Center database (www.poxvirus.org). In the Copenhagen sequence, the A26L ORF is formed by a large deletion which spans A25.2
and A25.3 and fuses the N-terminus of the p4c gene with sequence near the 3′ end of the ATI gene corresponding to the 3′ end of the A25.1L ORF. The A25L ORF in
WR and Copenhagen are approximately equivalent.
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Cts6/Cts9 truncation deletes the fourth conserved cysteine at
position 139 in the A28 protein, closest to the C-terminus.
Purified mature virions of Cts6 produced at both permissive
and nonpermissive temperatures contain the truncated A28
protein
Analysis of the defect in the Cts9 mutant in infected cells at
the nonpermissive temperature of 40 °C by electron microscopy
did not reveal any obvious abnormality. All of the stages of
virion morphogenesis were observed at both 31 °C and 40 °C,
and apparently normal mature virions were produced following
infection by Cts9 at 40 °C (data not shown). This finding was
consistent with earlier observations that protein and DNA
synthesis were not grossly perturbed in the mutant infection
(Condit and Motyczka, 1981).
The presence of mutant A28 protein in the virions produced
at both 31 °C and 40 °C was investigated by immunoblotting
with a polyclonal antibody against a synthetic peptide spanning
residues 56–75 of wild-type A28 protein (Materials and
methods). The antibody enabled visualization of the wild-type
A28 protein in purified MV of wild-type virus (Fig. 3A). A
similar band was not detected in extracts from uninfected cells
(data not shown). A faster migrating band relative to the wt A28
protein was detected in purified MV of Cts9 grown at either
31 °C or at 40 °C (Fig. 3A), indicating that the truncated A28protein remained associated with virions synthesized at either
temperature. The mobility difference between wt and Cts9 A28
protein was clearly visible following extended electrophoresis
in a 10–20% gradient Tris–tricine gel (Fig. 3A) but was less
evident following separation for shorter times (Fig. 3B).
The partitioning of wt and Cts9 A28 protein into membrane
(soluble) and core (insoluble) fractions was followed after
treatment of virions with 1% NP-40 detergent in the absence or
presence of the reducing agent DTT. The pellet and supernatant
fractions were separately probed with antibodies against A28,
A27, L1, and F17 (Fig. 3). The A28 protein has a predicted
transmembrane domain from residues 4–26, and this region is
unaltered in the Cts9 mutant. However, wt A28 protein did not
partition as expected for a membrane protein, and was found
predominantly in the insoluble fraction after treatment with both
detergent and DTT (Fig. 3B). Senkevich et al. (2004a) also
found that A28 was only partially solubilized by NP40, and
remained core associated after incubation of virions with both
NP-40 and DTT. The Cts9 A28 protein behaved in a manner
similar to wt A28. Traces of wt A28 protein were detected in the
soluble fraction of wild-type MV grown at 31 °C or 40 °C (Fig.
3B). The Cts9 protein appeared somewhat less abundant than
the wt A28 protein, and was not detectable in the soluble
fraction. The absence of the Cts9 protein from the soluble
fraction may reflect either intrinsically reduced solubility of the
mutant protein, or possibly altered interactions with other virion
components.
Fig. 2. Sequences of the A28 gene and protein from wild-type VVand from Cts6 and Cts9. (A) Nucleotide alignment of the 3′ end of the A28L gene from wild-type,
Cts6, and Cts9 viruses. In Cts6 and Cts9 cytosine residues located at positions 394 and 395 are deleted, which are indicated by ^ ^ below the sequence. (B) Amino acid
sequence alignment of A28 protein from wild-type, Cts6, and Cts9. The first 131 amino acids are identical in mutant and wild-type viruses. The deletion of the two
adjacent C residues causes a frameshift which results in three amino acid substitutions (indicated by * under the sequence) followed by a premature stop codon causing
truncation. Conserved cysteine residues are indicated by “C” in boldface. The A28 protein in our laboratory isolate of vaccinia WR was found to contain asparagine at
position 124 rather than the aspartic acid expected from the published sequence (Senkevich et al., 2004a). A similar N124 substitution relative to the published VVWR
sequence was found in the A28 protein of VV Copenhagen (Goebel et al., 1990) and of VV strain MVA. (C) A diagram of the wt and mutant A28 proteins. A
transmembrane domain, indicated by a gray box and labeled TM, is located between the 4th and 26th amino acids. The open box at the C-terminal end of the mutant
protein represents the three substitutions encoded by the mutant viruses, which begin at amino acid 132. The Cs inside the proteins represent conserved cysteines.
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solubilized efficiently by treatment with 1% NP-40 in both the
absence and presence of DTT (Fig. 3B). The core protein F17,
previously known as VP11 (Kao and Bauer, 1987), was present
exclusively in the insoluble fraction following treatment with
detergent alone (Fig. 3B). A27 (sometimes called the 14-kDa
fusion protein), is a membrane-associated protein that interacts
with the membrane protein A17 (Rodriguez et al., 1993),
although A27 is not itself an integral membrane protein. We
detected A27 in both the soluble and insoluble fractions
following detergent treatment of wt or Cts9 virions grown at
40 °C, but A27 was almost entirely soluble following detergent
and DTT treatment (Fig. 3B). The proportion of A27 that was
soluble from virions grown at 31 °C also increased in the
presence of DTT (Fig. 3B).
The synthesis of virions in the presence of truncated Cts9
A28 protein at either 31 °C or 40 °C did not alter the amounts or
fraction distribution of A27, L1, or F17 in comparison with
virions containing wt A28 protein produced at the same
temperature (Fig. 3B), suggesting that Cts9 intracellular virionswere not grossly perturbed in their assembly, even when
assembled at 40 °C. The biological properties of Cts9 mutant
virions were assessed by determining their ability to yield
plaques and cytopathic effect when added to cells.
Cts9 virus particles produced at 40 °C have an elevated
particle/pfu ratio, and are unable to produce cytopathic effect
at 31 °C
Mature virions were purified from BSC-40 cells infected
with either wtVV or Cts9, at 31 °C or 40 °C, and the yield
measured in terms of both particles (by optical density) and
infectious virus (by plaque assay at 31 °C). The Cts9 mutant
produced a normal yield of virus particles per infected cell at
40 °C of approximately 1000 (Table 1), which was similar to the
value of 1067 obtained for wtVV grown at 40 °C. Particle
production by Cts9 at 31 °C was also normal (Table 1), and
similar to that seen for wtVVunder comparable conditions. Cts9
particles from infection at 31 °C had a particle/pfu ratio of 42
and were thus almost normal, although with a slightly higher
Table 1
Particle yield and particle/pfu ratio for WT and Cts9 viruses
Virus Growth
temperature (°C)
Yield
(particles/cell)
Particles/pfu
WT 31 1467 14
WT 40 1067 34
Cts9 31 1333 42
Cts9 40 1000 5101
Fig. 3. Immunoblot analysis of purified wild-type and mutant virions.
(A) Different mobilities of A28 protein from WT and Cts9 virions. Virions
were incubated in the presence of 50 mM Tris for 30 min at 37 °C, pelleted in a
microfuge for 30 min, and subjected to electrophoresis on a 10–20% acrylamide
Tris–tricine gel before immunoblotting with anti-A28 antibody. The nature of
the A28 allele (WT or Cts9) and the temperature at which the virions were
produced are shown above each lane. (B) Western blot analysis of protein
distribution in fractionated virions. Wild-type (WT) or mutant (Cts9) virions
grown at 31 °C or 40 °C were separated in the absence (−) or presence (+) of
DTT into core (pellet, P) and membrane (supernatant, S) fractions and run on a
10–20% Tris–tricine gel. Proteins were subjected to Western blot analysis with
anti-A28, anti-A27, anti-L1, or anti-F17 antibody, as indicated on the right.
Molecular weight markers are indicated on the left.
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particles from infection at 40 °C had a particle/pfu ratio of 5101,
approximately 150-fold higher than the corresponding value for
wtVV (Table 1).
The ability of non-infectious particles to cause cytopathic
effect was investigated. Confluent monolayers of BSC-40
cells were infected with purified MV from wild-type VV
grown at 31 °C or 40 °C, and from Cts9 grown at both
temperatures. A multiplicity of 5 was used, with an
equivalent number of particles for the Cts9 mutant grown
at 40 °C. The cells were incubated at 31 °C, and cytopathic
effect (CPE) was assessed following staining of cellular actin
with phalloidin-AlexaFluor 568 at 6 h p.i. Mock-infected
cells (Fig. 4A) showed no CPE, as expected. Purified MV of
wtVV grown at 40 °C gave extensive CPE, with cellshrinkage and rounding (Fig. 4B), as did wtVV virions
produced at 31 °C (not shown). Cts9 MV resulting from
infection at 31 °C induced CPE (Fig. 4C) similar to that seen
with wild-type MV. In contrast, Cts9 virions produced at
40 °C were unable to cause detectable CPE under the
conditions used here (Fig. 4D).
Mature virions of Cts9 generated at 40 °C are able to bind to
cells, but are unable to produce intracellular cores
The inability of Cts9 virus particles produced at the
nonpermissive temperature to cause cytopathic effect sug-
gested that they were defective in a very early step of the
virus lifecycle, such as binding of virions to cells, entry into
cells, or early transcription. An analysis of purified Cts9
virions grown at 40 °C for ability to carry out transcription in
vitro at 31 °C indicated that these virions were not defective
in transcription (data not shown), suggesting that the virions
may be unable to bind to cells, or to enter into cells. We
tested for binding of purified virions by incubating cells with
virions at room temperature and then staining with mono-
clonal antibody against the A27 protein, an abundant
component of IMV. The results (Fig. 5, top row) clearly
indicated that Cts9 virions produced at either 31 °C or 40 °C
were able to bind to cells. Entry of virions was followed by
binding purified MV to cells at room temperature, transferring
to 31 °C to allow virus entry to occur, and then staining for
intracellular virus cores with A4 antibody (Rodriguez et al.,
1985). The core proteins do not become accessible to
antibody until after uncoating, even with virion permeabiliza-
tion (Vanderplasschen et al., 1998). Using this method,
intracellular cores were readily detected following infection
with wtVV grown at either temperature, and after infection
with Cts9 virions produced at 31 °C (Fig. 5, lower row).
However, under the same conditions Cts9 MV produced at
40 °C was almost entirely defective in generating intracellular
cores, with only one or two cores at most visible per cell, in
contrast with the abundant cores visible from the other
infections (Fig. 5). The defect in non-infectious Cts9 virions
therefore appeared to be specifically in between virus binding
and the generation of intracellular cores, i.e., at the step of
virus entry or uncoating. A defect in virus entry might be
associated with alterations in cell–cell fusion mediated by
cell-associated enveloped virus (fusion from within) or by
bound MV (fusion from without). In contrast, mutation
affecting uncoating would not be expected to alter the
fusogenic properties of virus particles.
Fig. 4. Lack of cytoplasmic effect following infection with Cts9 virions produced at the nonpermissive temperature. BSC-40 cells were mock-infected (A), or infected
at 31 °C with purified MVof wtVV grown at 40 °C (B), with Cts9 virions grown at 31 °C (C), or with Cts9 virions produced at 40 °C (D). At 6 h p.i., the cells were
fixed and stained for actin with phalloidin-AlexFluor 568.
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40 °C, and is partially defective at 31 °C
Cell–cell fusion is thought to reflect virus–cell fusion events
that occur during the entry of virus into susceptible cells. WeFig. 5. Binding of Cts9 virions to cells but lack of entry. The upper four panels show b
31 °C or 40 °C. CV-1 cells were infected at a multiplicity of 10 (for WT VVor Cts9
particles. Following adsorption of virions to cells for 1 h at room temperature, the cel
secondary Ab. The virions were pseudocolored cyan. Nuclei were counterstained by
assay. Mature virions were adsorbed to cells at RT, and the cells transferred to 31 °C
stained with rabbit anti-A4 serum followed by goat anti-rabbit FITC (green) to visual
cells were photographed with a Zeiss Axiovert 200 M inverted fluorescence microstested the Cts9 mutant for the ability to mediate fusion from
within at 31 °C and at 40 °C. Cells were infected with either
wtVVor Cts9 at a multiplicity of 5 at 31 °C or 40 °C, and treated
briefly at 16 h p.i. with buffer at pH 4.6. Low pH treatment
resulted in extensive cell–cell fusion following infection withinding to CV-1 cells of purified mature virions of either WT VVor Cts9 grown at
grown at 31 °C), or for Cts9 grown at 40 °C with an equivalent number of virus
ls were fixed and reacted with anti-A27 mAb followed by goat anti-mouse FITC
propidium iodide (red). The lower four panels show the result of the virus entry
for 2 h to allow virus entry to occur. The cells were fixed, permeabilized, and
ize intracellular cores. Counterstaining of nuclei was with propidium iodide. The
cope. Arrows in the lower panels indicate representative core particles.
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contrast microscopy (Fig. 6A). No fusion was observed after
treatment of the same infected cells with buffer at pH 7.4 (Fig.
6A). The Cts9 mutant produced clearly visible cell–cell fusion
at 31 °C following low pH treatment, but no cell–cell fusion
was observed at 40 °C after acid treatment (Fig. 6A).
The amount of cell–cell fusion produced by acid-treated
Cts9-infected cells at 31 °C seemed reduced relative to
similarly treated wtVV-infected cells (Fig. 6A). The extent ofFig. 6. Fusion from within by Cts9, and effect of temperature and multiplicity. (A
columns) or Cts9 (last two columns) at 31 °C (top row) or 40 °C (lower row). At 16
indicated above the panels, and incubated for a further 3 h in complete medium befor
by wtVVor Cts9 at 31 °C. BSC-40 cells were infected with wtVV (upper row) or Cts9
column), incubated for 16 h at 31 °C, briefly acid treated at pH 4.6, and photographcell–cell fusion was compared visually at 31 °C for acid-
treated cells that had been infected with wtVV or Cts9 at
multiplicities of 50, 5, and 0.5 (Fig. 6B). Fusion of wtVV-
infected cells was similar and essentially complete at each of
these multiplicities (Fig. 6B). In contrast, fusion mediated by
Cts9 at multiplicities of 50 and 5 was extensive but still
somewhat reduced compared with wtVV, and at an moi of 0.5,
Cts9 produced very little fusion. These results suggest that
Cts9 virions on the surface of infected cells are completely) Confluent BSC-40 cells were infected at moi=5 with either wtVV (first two
h p.i., the monolayers were treated for 2 min with PBS at pH 7.4 or pH 4.6, as
e phase contrast photomicrography. (B) Effect of multiplicity on fusion mediated
(lower row) at a multiplicity of 50 (left column), 5 (center column), or 0.5 (right
ed after 3-h incubation in medium.
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at 31 °C are partially defective.
Purified virions of Cts9 synthesized at 40 °C cannot cause
fusion from without
The ability of purified MV of Cts9 to cause fusion from
without was tested by adsorbing virions directly to cells at a
very high multiplicity or particle/cell ratio, subjecting the cells
to low pH, and then incubating at 31 °C to allow cell–cell fusion
to occur. Cycloheximide was present throughout to minimize
cytopathic effect. Actin was stained with fluorescent phalloidin-
AlexaFluor 568 to visualize the cytoskeleton, and nuclei were
counterstained with DAPI. Acid-treated cells to which virus had
not been added gave no fusion (Fig. 7A). Cells with adsorbed wt
virus gave no fusion after treatment at pH 7.4 (Fig. 7B), but
extensive fusion after low pH treatment, regardless of whether
the virus had been produced at 31 °C (Fig. 7C) or 40 °C (Fig.
7D). Treatment of cells to which Cts9 virus had been adsorbed
with pH 4.6 buffer resulted in a low level of fusion, with a few
multinucleate cells evident (Fig. 7E) but none of the giant
syncytia that were produced by wtVV (Fig. 7C). Adsorption of
Cts9 MV grown at 40 °C to cells gave no detectable fusion
following acid treatment (Fig. 7F), indicating that these mutant
virions were defective in fusion from without. The phenotype ofFig. 7. Fusion from without. BSC-40 monolayers were mock-infected (A), or infecte
presence of cycloheximide with purified MVof wtVV grown at 31 °C (B, C) or wit
Following virus adsorption and removal, all monolayers were briefly treated at pH 4
stained at 3 h post-treatment with DAPI for nuclei (blue) and with phalloidin-Alexathe Cts9 mutant is therefore consistent with the A28 protein
playing an essential role in the entry of mature virions into cells
by a process involving fusion between the virus and cell
membranes.
Discussion
The experiments described here show that deletion of the
C-terminal 14 amino acids of the vaccinia virus A28 protein
results in a temperature-sensitive phenotype. Cts9 virions
produced at the nonpermissive temperature are defective in
virus fusion with the cell membrane and entry into cells. The
Cts9 mutant in A28 was normal in terms of virus DNA and
protein synthesis at 40 °C, and no defects were observed in
processing of the core proteins p4a (A10) or p4b (A3), or in
virion morphogenesis (data not shown). However, mutant
infections done at 40 °C were defective in fusion from within,
and mutant virions purified from nonpermissive infections
bound to cells but were defective for fusion from without and
defective for virus entry as measured by the formation of
intracellular cores. This phenotype is virtually identical to the
phenotype described for a conditional lethal vaccinia mutant
which, under nonpermissive conditions, does not express A28
(Senkevich et al., 2004b); the same phenotype has been
described for several other proteins associated with the entry/d at moi=300 (or with an equivalent number of non-infectious particles) in the
h wtVV grown at 40 °C (D), or with Cts9 produced at 31 °C (E) or 40 °C (F).
.6 except for panel B, where monolayers were treated at pH 7.4. The cells were
Fluor 568 for actin (red).
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2005a, 2005b; Izmailyan et al., 2006; Ojeda et al., 2006a,
2006b). The principal difference between the ts mutant
described here and the inducible mutants described previously
is that under nonpermissive conditions, Cts9 produced virions
which contain mutant A28 protein, whereas in the inducible
mutants the A28 protein is absent from mutant virions. The
simplest mechanistic interpretation of the Cts9 mutant pheno-
type is that the C-terminus of the A28 protein, including the C-
terminal conserved cysteine, is important for the assembly of a
functional entry/fusion complex. Specifically we suggest that
the C-terminus of A28 may contribute to the stability of the
complex during assembly such that the truncated protein
functions relatively normally in assembly at 31 °C, but cannot
assemble stably into the entry/fusion complex during morpho-
genesis at 40 °C.
The finding that the Cts9 mutation truncated the A28 protein
at the C-terminus but was not lethal at 31 °C was unexpected in
view of the strong conservation of the A28 protein (Senkevich
et al., 2004a). It is noteworthy, however, that peptide tags can be
fused to the A28 carboxy terminus without loss of function.
Addition of the influenza hemagglutinin (HA) tag with serine
(YPYDVPDYAS) to the C-terminus of A28 was tolerated
(Senkevich et al., 2004a), and we have shown that a short linker
plus the FLAG tag (LEDYKDDDDK) can similarly be
appended to A28 to produce a viable virus (data not shown).
The removal of the fourth conserved cysteine in Cts9 must
disrupt one of the two conserved disulfide bridges in the A28
protein, and loss of this disulfide bridge appears to be
detrimental to the functioning of the A28 protein at 40 °C. It
may be of interest in the future to assess the individual
contributions of the four conserved cysteines to the structure
and function of the entry/fusion complex.
The precise functioning of the A28 protein in entry
remains to be determined. Although Cts9 virions made at
40 °C bound normally to cells, binding may initially be
mediated via a low-affinity attachment factor rather than
directly to the putative cellular receptor which allows entry,
and it is not clear if A28 (or any of the other proteins in the
entry/fusion complex) interacts directly with the receptor.
Future work is aimed at elucidating how A28 functions to
mediate entry, a goal that may require identification of the
cellular receptor to be fully realized.
Materials and methods
Cells and viruses
BSC40 cells (ATCC CRL-2761, epithelial cells derived
from African green monkey kidney) were used for propagating
and titering wild-type vaccinia virus strain WR and mutants
Cts6 and Cts9 (Condit and Motyczka, 1981). CV-1 cells
(ATCC CCL-70, African green monkey kidney cells) were
used in experiments involving immunofluorescence micro-
scopy. Cells infected with the ts mutants were grown at either
31 °C (permissive temperature) or 40 °C (nonpermissive
temperature).Marker rescue
Marker rescue was performed as previously described
(Thompson and Condit, 1986; Meis and Condit, 1991).
Briefly, cells were infected with mutant virus at an moi of
approximately 0.03 pfu/cell, transfected with PCR products
amplified from wt vaccinia DNA, incubated at 40 °C for
4 days, and then stained with crystal violet. PCR products
used in the rescue were generated using primers that precisely
amplified individual open reading frames (ORFs) or clusters
of adjacent ORFs. Integrated DNA Technologies, Inc. (IDT
Coralville, IA) synthesized all oligonucleotides used as
primers.
DNA sequence analysis
DNA sequence of the A27L and A28L genes from wt, Cts6,
and Cts9 viruses was obtained by direct sequencing of PCR
products amplified from total infected cell DNA. Qiagen
DNeasy miniprep spin columns were used to isolate total
infected cell DNA according to the manufacturer's instructions
for isolation from cells in culture as previously described
(Latner et al., 2000). DNA sequencing was done by the
University of Florida ICBR DNA Sequencing Core Laboratory.
Purification of virus particles and measurement of particle/pfu
ratio
Confluent monolayers of BCS40 cells in 150-mm dishes
were infected with wt, Cts6, or Cts9 viruses at an moi of 10 and
incubated at 31 °C or 40 °C. Infected cells incubated at 40 °C
were harvested at 24 h after infection while infected cells
incubated at 31 °C were harvested at 72 h after infection. Virus
purification was performed by sedimentation through pre-
formed sucrose density gradients as described (Ausubel et al.,
1994). Purified virions were quantified by optical density at
260 nm (1 OD260=64 μg/ml virus=1.2×10
10 virus particles/
ml). Infectivity of the purified virus was assayed by plaque
titration on BSC40 cells at 31 °C or 40 °C.
Antibodies and immunoblotting
Rabbit polyclonal antiserum against the peptide DRRVQDV-
NDTISDVKQKWRC spanning amino acids 56–75 of A28
protein was generated by SigmaGenosys. Mouse mAb
5AG8 against A27 was obtained from David Ulaeto (DSTL
Porton Down, UK), and rabbit antibodies against L1 and
F17 from Paula Traktman (Medical College of Wisconsin,
Milwaukee).
Purified virions (0.1 OD) were incubated at 37 °C for 30 min
in buffer containing 50 mM Tris and 1% NP40, with or without
50 mM DTT. Cores and membranes were isolated by
centrifuging the virions in a microfuge for 30 min at
13,000 rpm and separating the supernatant from the pellet.
Proteins were run on a 10–20% Tris–tricine gel (BioRad) and
visualized by immunoblotting with antibodies against A28,
A27, L1, or F17.
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Infected cells were fixed with PBS containing 4% paraf-
ormaldehyde (PFA) for 10 min, permeabilized with PBS/0.05%
Saponin, and stained with a 1:20 dilution of phalloidin-
AlexaFluor 568 (Molecular Probes, now Invitrogen) in PBS/
1% BSA for 20 min. Texas Red filters were used to visualize
stained cells.
Virus binding and entry
To assess virus binding, purified MV was added to CV-1
cells grown to 50% confluence in 8-chamber culture slides (BD
Biosciences) at a multiplicity of 50, or an equivalent number of
particles per cell, and adsorbed for 1 h at 4 °C. After washing 3
times to remove unbound virus, the cells were fixed with PBS/
4% PFA for 10 min on ice, then 20 min at room temperature
(RT). Following one wash with PBS, any remaining fixative
was quenched with PBS/20 mM glycine for 5 min. The cells
were blocked with PBS/10% fetal bovine serum (FBS) for
10 min at RT, and anti-A27 mAb 5AG8 added in PBS/10% FBS
for 1 h at RT. After 3 washes, goat anti-mouse FITC secondary
antibody (Jackson ImmunoResearch Laboratories) diluted
1:100 in PBS/10% FBS was added for 30 min at RT. Following
two PBS washes, cells were stained with PBS/0.05% Saponin
containing 0.25 μg/ml DAPI, and bound virions visualized by
fluorescence using a Zeiss Axiovert 200 M microscope.
Entry of purified MV into cells was monitored by staining for
intracellular cores with rabbit antibodies against the A4 core
protein (from Mariano Esteban at the Centro Nacional de
Biotecnología, Campus Universidad Autónoma, Madrid,
Spain). CV-1 cells were infected as above at 4 °C. After
removing unadsorbed virus, medium containing 100 μg/ml
cycloheximide was added, and the cells incubated at 31 °C for
2 h to allow entry to occur, or at 4 °C as a negative control. Cells
were fixed, quenched, and blocked as above, then permeabi-
lized with PBS/0.1% Saponin for 10 min at RT. Rabbit anti-A4
serum diluted 1:250 in PBS/10% FBS was added for 1 h at RT,
and after washing goat anti-rabbit FITC (Jackson ImmunoR-
esearch Laboratories) added. Nuclei were counterstained with
propidium iodide, and imaged by fluorescence microscopy.
Fusion from within and without
Confluent monolayers of BSC-40 cells were infected with
either wtVVor Cts9 at 31 °C or 40 °C, and at 18 h p.i. washed
with PBS, and treated for 2 min with PBS at either pH 7.4 or pH
4.6. After incubation for a further 3 h in medium, the extent of
fusion from within was assessed visually by phase contrast
microscopy.
For fusion from without, purified MV was added to BSC-40
cells at moi=300 (or an equivalent number of virus particles for
Cts9 grown at 40 °C), and allowed to adsorb for 1 h at 4 °C.
After one PBS wash, cells were treated for 2 min at RT with
warmed PBS at pH 7.4 or pH 4.6, then incubated for 4 h at 31 °C
in medium containing 100 μg/ml cycloheximide. Cells were
fixed with PBS/4% PFA, and stained with DAPI and phalloidin-AlexaFluor 568 in PBS/0.05% Saponin, and photographed by
fluorescence microscopy.
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